New York, NY - (ACCESSWIRE) - 11/25/2013 - Equity Profile Report initiates its NASDAQ Active Stock Watch List adding Orexigen Therapeutics, Inc. (NASDAQ:OREX), Camtek Ltd. (NASDAQ:CAMT), Celldex Therapeutics, Inc. (NASDAQ:CLDX), and Glu Mobile, Inc. (NASDAQ:GLUU)
Orexigen Therapeutics, Inc. (NASDAQ:OREX) a biopharmaceutical company that focuses on the development of pharmaceutical product candidates for the treatment of obesity is currently up (+11.36%) on 4,634,564 shares traded after Orexigen Announced Successful Interim Analysis of Contrave Light Study. Orexigen Therapeutics, Inc. (NASDAQ:OREX) is currently up (+44.71%) from its recent 52-week low, which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List and Investor Poll.
To find out what other Investors are saying about Orexigen Therapeutics, Inc. (NASDAQ:OREX)Click Here: http://www.equityprofilereport.com/Survey.aspx?stock=OREX&SubId=AW
Camtek Ltd. (NASDAQ:CAMT) a company that together with its subsidiaries, designs, develops, manufactures, and markets automatic optical inspection systems and related products is currently up (+71.32%) on 6,999,845 shares traded after Camtek Announced to Present at LD MICRO's 6th Annual Conference On Wednesday, December 4, 2013. Camtek Ltd. (NASDAQ:CAMT) is currently up (+303.05%) from its recent 52-week low, which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List and Investor Poll.
To find out what other Investors are saying about Camtek Ltd. (NASDAQ:CAMT)Click Here: http://www.equityprofilereport.com/Survey.aspx?stock=CAMT&SubId=AW
Celldex Therapeutics, Inc. (NASDAQ:CLDX) a biopharmaceutical company that focuses on the development, manufacture, and commercialization of novel therapeutics for human health care primarily in the United States is currently down (-8.80%) on 1,820,427 shares traded after CELLDEX THERAPEUTICS, INC. Filed SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits. Celldex Therapeutics, Inc. (NASDAQ:CLDX) is currently down (-34.5%) from its recent 52-week high, which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List and Investor Poll.
To find out what other Investors are saying about Celldex Therapeutics, Inc. (NASDAQ:CLDX)Click Here: http://www.equityprofilereport.com/Survey.aspx?stock=CLDX&SubId=AW
Glu Mobile, Inc. (NASDAQ:GLUU) a company that develops and publishes a portfolio of action/adventure and casual games for the users of smartphones and tablet devices is currently up (+3.85%) on 1,184,404 shares traded. Glu Mobile, Inc. (NASDAQ:GLUU) is currently up (+92%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List and Investor Poll.
To find out what other Investors are saying about Glu Mobile, Inc. (NASDAQ:GLUU)Click Here: http://www.equityprofilereport.com/Survey.aspx?stock=GLUU&SubId=AW
Equityprofilereport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals Equityprofilereport.com is often aware of several large investor awareness campaigns being deployed.Timing is important when trading Small Caps and Penny Stocks.Simply sign up for free and start receiving exclusive alerts.
Subscribe Here: http://www.equityprofilereport.com/Disclosure: Equityprofilereport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Equityprofilereport.com website, for complete risks and disclosures.
Contact Info:Equity Profile Report
[email protected]